Consumer Care
- Net sales in 2010: EUR 3,371 million
- Headquarters: Morristown, New Jersey (USA)
A growing number of individuals worldwide select medicines themselves for the preven-tion or treatment of common ailments, as well as nutritional supplements to support a healthy diet. Many of them place their trust in tried-and-true nonprescription or over-the-counter (OTC) products from Bayer HealthCare's Consumer Care Division. One example is Aspirin, a more than 110-year-old brand that enjoys an unsurpassed level of global familiarity.
Consumer Care currently ranks among the top consumer healthcare companies in the world. The division operates in more than 140 countries and maintains 14 manufacturing sites and two product research and development centers. With more than 170 brands around the world and eight global brands generating annual sales of more than € 100 million each, Consumer Care is well positioned to take advantage of the sustained growth forecast for the OTC market.
The division holds a balanced portfolio of strong brands in all major OTC categories, in-cluding analgesics, cardiovascular risk prevention, cough and cold, dermatology, gastro-intestinal and nutritionals. In fact, some of the world’s best-known and most trusted over-the-counter medications and nutritional supplements including Aspirin, Aleve, Alka Seltzer, Bepanthen/Bepanthol, Berocca, Canesten, Elevit, Redoxon, Rennie, Supradyn, Talcid and One A Day are part of the Consumer Care portfolio.
The division has a strong track record of growth in emerging markets and continues to invest in fast-growing regions around the world to increase its global footprint and ad-vance its international portfolio of products. Recent investments including the acquisitions of Topsun Science & Technology in China and Sagmel Inc. in Eastern and Central Europe are excellent examples of this. In 2009, Consumer Care also executed on its Rx-to-OTC switch strategy with the launch of the OTC proton pump inhibitor (PPI) omeprazole under the brand names Antra and Losec through an exclusive licensing agreement with Astra-Zeneca.
Consumer Care generated sales of € 3.4 billion or 19.9 percent of Bayer HealthCare’s total sales in 2010.
Among its most well-known brands are:
The division holds a balanced portfolio of strong brands in all major OTC categories, in-cluding analgesics, cardiovascular risk prevention, cough and cold, dermatology, gastro-intestinal and nutritionals. In fact, some of the world’s best-known and most trusted over-the-counter medications and nutritional supplements including Aspirin, Aleve, Alka Seltzer, Bepanthen/Bepanthol, Berocca, Canesten, Elevit, Redoxon, Rennie, Supradyn, Talcid and One A Day are part of the Consumer Care portfolio.
The division has a strong track record of growth in emerging markets and continues to invest in fast-growing regions around the world to increase its global footprint and ad-vance its international portfolio of products. Recent investments including the acquisitions of Topsun Science & Technology in China and Sagmel Inc. in Eastern and Central Europe are excellent examples of this. In 2009, Consumer Care also executed on its Rx-to-OTC switch strategy with the launch of the OTC proton pump inhibitor (PPI) omeprazole under the brand names Antra and Losec through an exclusive licensing agreement with Astra-Zeneca.
Consumer Care generated sales of € 3.4 billion or 19.9 percent of Bayer HealthCare’s total sales in 2010.
Among its most well-known brands are:
- Analgesics:
Bayer Aspirin®, Aleve®, Aktren® and Midol® - Gastrointestinal products:
Alka-Seltzer®, Antra®, Lefax®, Phillips'® Milk of Magnesia, Rennie® and Talcid® - Dermatological/topical products:
Bepanthen®, Bepanthol®, Canesten®, RID®, Germolene®, Germoloids® and Bactin® - Cough and cold remedies:
Alka-Seltzer Plus®, Aleve® Cold & Sinus and Tabcin® - Multivitamins and dietary supplements:
Berocca®, One-A-Day®, Pluravit®, Supradyn®, Flintstones®, Elevit® and Redoxon®
Intendis
Intendis is an integrated pharmaceutical business headquartered in Berlin, Germany. As part of Bayer HealthCare, Intendis is completely dedicated to dermatology and focuses on the development, manufacturing and marketing of high quality, innovative topical therapies, targeted to treat skin disorders. The current product portfolio comprises treatments of eczema disorders including atopic dermatitis, as well as psoriasis, acne, rosacea, hemorrhoids and fungal skin infections (mycoses).More information about our other Divisions
Search
Bayer HealthCare Links
Financial Report
